Thrombohemorrhagic complications of myeloproliferative disorders

Blood Rev. 2010 Nov;24(6):227-32. doi: 10.1016/j.blre.2010.08.002.

Abstract

Myeloproliferative disorders are commonly associated with thrombohemorrhagic manifestations. The current review highlights recent advances in understanding the epidemiology and pathogenetic mechanisms of thrombotic and bleeding complications. Therapeutic modalities and prophylactic interventions corresponding to the specific disease states are also discussed.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Humans
  • Myeloproliferative Disorders / complications*
  • Myeloproliferative Disorders / drug therapy
  • Myeloproliferative Disorders / epidemiology
  • Thrombosis / complications*
  • Thrombosis / drug therapy
  • Thrombosis / epidemiology

Substances

  • Antineoplastic Agents